CNS Pharmaceuticals, Inc. (CNSP) shares skyrocketed 263.46 percent to $8.40, gaining $6.09 on Monday, following the announcement of a significant private placement financing.
The stock is currently trading at $8.40, compared to its previous close of $2.31 on the Nasdaq. It opened sharply higher at $9.23 and has traded in a range of $8.84 to $10.54, with volume surging to 59,237,149 shares.
The company announced it has entered into securities purchase agreements expected to generate approximately $22.5 million in gross proceeds. The financing includes participation from institutional healthcare investors and involves the sale of common stock and pre-funded warrants. CNS plans to use the proceeds to acquire and advance new assets aligned with its updated corporate strategy.
The stock has traded between $1.90 and $34.80 over the past 52 weeks.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.